


| Key | % Net Assets |
|---|---|
| 3.5% | |
| 3.1% | |
| 3.0% | |
| 2.9% | |
| 87.5% |
| Name | % Net Assets |
|---|---|
| Reynolds American | 3.5% |
| Roche | 3.1% |
| Vodafone | 3.0% |
| Koninklijke KPN | 2.9% |
| Philip Morris International | 2.8% |
| Novartis | 2.8% |
| Johnson & Johnson | 2.7% |
| Jardine Matheson | 2.1% |
| National Grid | 2.1% |
| Hewlett Packard | 2.0% |
No asset data available.
| Date | 20-Aug-2025 |
|---|---|
| NAV | 198.87p |
| Currency | GBP |
| Change | 0.020p |
| % | 0.01% |
| YTD change | 12.39p |
| YTD % | 6.64% |
| Fund Inception | 02/03/2009 |
|---|---|
| Fund Manager | n/a |
| TER | 1.69 (31-Dec-2013) |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.67% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research